Medicare Enrolled

Dr. Thomas Takayama, M.D.

Urology Physician · Bellevue, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1135 116TH AVE NE, Bellevue, WA 98004
4254548016
In practice since 2006 (19 years)
NPI: 1720166184 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Takayama from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Takayama? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Takayama

Dr. Thomas Takayama is an urology physician in Bellevue, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Takayama performed 776 Medicare services across 662 unique beneficiaries.

Between the years covered by Open Payments, Dr. Takayama received a total of $2,159 from 29 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Takayama is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 776 Medicare services $2,159 industry payments

Medicare Practice Summary

Medicare Utilization ↗
776
Medicare services
Bottom 40% in WA for urology physician
662
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~41 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
244 $95 $357
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
86 $197 $727
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
74 $10 $32
Bladder emptying assessment
A timed evaluation to measure how effectively the bladder empties urine.
64 $11 $37
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
46 $130 $462
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
40 $13 $41
Injection, garamycin, gentamicin, up to 80 mg 39 $2 $2
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
37 $67 $230
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
33 $124 $501
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
28 $164 $701
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
27 $131 $620
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
27 $54 $167
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
16 $3 $5
Laser prostate fragmentation with bleeding control
This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope.
15 $714 $2,233
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,159
Total received (2018-2024)
Avg $360/year across 6 years
Top 44% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,824 (84.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$335 (15.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$517
2022
$486
2021
$332
2020
$271
2019
$444
2018
$110

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$182
ABBVIE INC.
$93
PROGENICS PHARMACEUTICALS, INC.
$56
180 Medical, Inc.
$49
Myriad Genetic Laboratories, Inc.
$40
Janssen Biotech, Inc.
$30
Baxter Healthcare
$19
Ferring Pharmaceuticals Inc.
$19
Antares Pharma, Inc.
$15
ABC Home Medical Supply, Inc.
$14
Top 3 companies account for 64.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$354
180 Medical, Inc.
$272
Antares Pharma, Inc.
$243
Sumitomo Pharma America, Inc.
$182
Myriad Genetic Laboratories, Inc.
$146
Boston Scientific Corporation
$120
ABBVIE INC.
$93
TherapeuticsMD, Inc.
$84
Coloplast Corp
$81
ConvaTec Inc.
$79
PROGENICS PHARMACEUTICALS, INC.
$56
Janssen Biotech, Inc.
$54
UROVANT SCIENCES INC
$49
Bayer HealthCare Pharmaceuticals Inc.
$43
UroGen Pharma, Inc.
$38
Ferring Pharmaceuticals Inc.
$35
AMAG Pharmaceuticals, Inc.
$26
Zyla Life Sciences, Inc.
$24
Sagent Pharmaceuticals, Inc.
$20
Baxter Healthcare
$19
Abbott Laboratories
$19
Profound Medical Corp.
$18
Smith+Nephew, Inc.
$17
PFIZER INC.
$16
Medtronic USA, Inc.
$15
NxThera, Inc.
$15
ABC Home Medical Supply, Inc.
$14
Endo Pharmaceuticals Inc.
$14
Rochester Medical Corporation
$12
Top 3 companies account for 40.3% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANCE · AVYCAZ · BOTOX · BRAC CDx · BRACANALYSIS CDX · ERLEADA · FIRMAGON · GEMTESA · GENERAL - ONCOLOGY · GENTLECATH · Glydo · IMVEXXY · INTERSTIM · INTRAROSA · JELMYTO · LUPRON DEPOT · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · OTREXUP · PREMARIN · PROLARIS · PYLARIFY · Prolaris · Rezum · SPEEDICATH · SPRIX · STRAVIX · TISSEEL · Tulsa-Pro · Vysis UroVysion · XIAFLEX · XTANDI · XYOSTED · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Bellevue?
Compare urology physicians in the Bellevue area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
170
Per 100K population
7.5
County median income
$122,148
Nearest hospital
OVERLAKE HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Takayama is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Takayama experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Takayama performed 244 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Takayama receive payments from pharmaceutical companies?
Yes. Dr. Takayama received a total of $2,159 from 29 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Takayama's costs compare to other urology physicians in Bellevue?
Dr. Takayama's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Takayama) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →